Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04791839
Brief Title: Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer

First Submitted : March 5, 2021
First Submitted that Met QC Criteria : March 5, 2021
First Posted : March 10, 2021

Last Update Submitted that Met QC Criteria : September 16, 2021
Last Update Posted : September 17, 2021